Guardian Wealth Advisors (North Carolina)’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3M Buy
11,906
+43
+0.4% +$9.25K 0.17% 88
2026
Q1
$2.58M Sell
11,863
-230
-2% -$51K 0.16% 88
2025
Q4
$2.76M Buy
12,093
+4
+0% +$911 0.17% 83
2025
Q3
$2.8M Sell
12,089
-492
-4% -$100K 0.18% 79
2025
Q2
$2.34M Buy
12,581
+3,855
+44% +$716K 0.16% 85
2025
Q1
$1.83M Buy
8,726
+165
+2% +$32.1K 0.15% 89
2024
Q4
$1.52M Buy
8,561
+761
+10% +$140K 0.12% 105
2024
Q3
$1.54M Sell
7,800
-213
-3% -$39.8K 0.16% 81
2024
Q2
$1.37M Sell
8,013
-34
-0.4% -$5.63K 0.16% 78
2024
Q1
$1.47M Buy
8,047
+239
+3% +$41.2K 0.18% 78
2023
Q4
$1.21M Sell
7,808
-433
-5% -$63.1K 0.18% 76
2023
Q3
$1.23M Buy
8,241
+50
+0.6% +$7.34K 0.21% 71
2023
Q2
$1.1M Buy
8,191
+379
+5% +$55.6K 0.19% 72
2023
Q1
$1.25M Buy
7,812
+1,337
+21% +$204K 0.22% 61
2022
Q4
$1.05M Buy
6,475
+6
+0.1% +$920 0.2% 64
2022
Q3
$868K Sell
6,469
-826
-11% -$119K 0.16% 70
2022
Q2
$1.12M Buy
7,295
+1,768
+32% +$270K 0.2% 56
2022
Q1
$896K Sell
5,527
-167
-3% -$24.3K 0.39% 45
2021
Q4
$771K Buy
+5,694
New +$673K 0.33% 57

Other funds holding ABBV

Guardian Wealth Advisors (North Carolina)'s ABBV Position: Q2 2026 in Review

Guardian Wealth Advisors (North Carolina) increased its AbbVie (ABBV) stake by 0.36% in Q2 2026, buying an estimated $9.25K and bringing the position to 11,906 shares worth $3M. The position accounts for 0.17% of the portfolio, ranked #88.

Guardian Wealth Advisors (North Carolina) first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Guardian Wealth Advisors (North Carolina) held 11,906 shares of AbbVie worth $3M as of Q2 2026.
  • Guardian Wealth Advisors (North Carolina) bought 43 AbbVie shares in Q2 2026, an estimated $9.25K.
  • AbbVie made up 0.17% of Guardian Wealth Advisors (North Carolina)'s portfolio in Q2 2026, its #88 holding.
  • Guardian Wealth Advisors (North Carolina) first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Guardian Wealth Advisors (North Carolina)'s 13F filing for Q2 2026, filed 14 Aug 2026.